Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kaken Pharmaceutical Co Ltd

+ Add to Watchlist

4521:JP

4,075.0 JPY 25.0 0.61%

As of 02:00:00 ET on 05/29/2015.

Snapshot for Kaken Pharmaceutical Co Ltd (4521)

Open: 4,105.0 Day's Range: 4,045.0 - 4,135.0 Volume: 464,000
Previous Close: 4,100.0 52wk Range: 2,004.0 - 4,750.0 1-Yr Rtn: +104.83%

Stock Chart for 4521

No chart data available.
  • 4521:JP 4,065.0
  • 1D
  • 1M
  • 1Y
4,100.0
Interactive 4521 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4521

Current P/E Ratio (ttm) 27.9973
Estimated P/E(03/2016) 18.5408
Relative P/E vs. TPX 1.4749
Earnings Per Share (JPY) (ttm) 145.5500
Est. EPS (JPY) (03/2016) 219.7850
Est. PEG Ratio -
Market Cap (M JPY) 394,783.80
Shares Outstanding (M) 96.88
30 Day Average Volume 554,400
Price/Book (mrq) 4.3791
Price/Sale (ttm) 3.6156
Dividend Indicated Gross Yield 1.67%
Cash Dividend (JPY) 34.0000
Dividend Ex-Date 09/28/2015
5 Year Dividend Growth 14.48%
Next Earnings Announcement 08/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4521

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4521

KAKEN PHARMACEUTICAL CO., LTD. develops, produces, and sells pharmaceuticals and agrochemicals. The Company's products are mainly for nervous, circulatory, respiratory, digestive, urinary, sensory, and metabolic systems. Kaken Pharmaceutical also manufactures antibiotics and feed additives. The Company as well manufactures air purifiers and operates real estate business.

Tetsuo OhnumaPresidentHirokazu KonishiExecutive Managing Director
Yoshihiro IedaExecutive Managing DirectorNoboru ShibataExecutive Managing Director
More Company Profile & Key Executives for 4521

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil